These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11252712)

  • 1. Tandem mass spectrometry in newborn screening. American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group.
    American College of Medical Genetics/American Society of Human Genetics Test and Technology Transfer Committee Working Group
    Genet Med; 2000; 2(4):267-9. PubMed ID: 11252712
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry.
    Leonard JV; Dezateux C
    BMJ; 2002 Jan; 324(7328):4-5. PubMed ID: 11777783
    [No Abstract]   [Full Text] [Related]  

  • 3. Newborn screening and genetic testing.
    Lloyd-Puryear MA; Forsman I
    J Obstet Gynecol Neonatal Nurs; 2002; 31(2):200-7. PubMed ID: 11926404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple acyl-coenzyme A dehydrogenase deficiency: diagnosis by acyl-carnitine analysis of a 12-year-old newborn screening card.
    Poplawski NK; Ranieri E; Harrison JR; Fletcher JM
    J Pediatr; 1999 Jun; 134(6):764-6. PubMed ID: 10356148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine. Fast technology drives new world of newborn screening.
    Marshall E
    Science; 2001 Dec; 294(5550):2272-4. PubMed ID: 11743177
    [No Abstract]   [Full Text] [Related]  

  • 6. Neonatal screening for medium--chain acyl-CoA dehydrogenase deficiency.
    Fowler DJ; Picker J; Waisbren SE; Levy HL
    Lancet; 2002 Feb; 359(9306):628. PubMed ID: 11867144
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudo-glutarylcarnitinaemia in medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry newborn screening.
    Napolitano N; Wiley V; Pitt JJ
    J Inherit Metab Dis; 2004; 27(4):465-71. PubMed ID: 15303003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany).
    Sander S; Janzen N; Janetzky B; Scholl S; Steuerwald U; Schäfer J; Sander J
    Eur J Pediatr; 2001 May; 160(5):318-9. PubMed ID: 11388605
    [No Abstract]   [Full Text] [Related]  

  • 9. One more thought on sudden infant death syndrome.
    Albers S; Levy HL
    Pediatrics; 2001 Apr; 107(4):809. PubMed ID: 11380009
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin.
    Van Calcar SC; Baker MW; Williams P; Jones SA; Xiong B; Thao MC; Lee S; Yang MK; Rice GM; Rhead W; Vockley J; Hoffman G; Durkin MS
    Mol Genet Metab; 2013; 110(1-2):111-5. PubMed ID: 23712021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis.
    Venditti LN; Venditti CP; Berry GT; Kaplan PB; Kaye EM; Glick H; Stanley CA
    Pediatrics; 2003 Nov; 112(5):1005-15. PubMed ID: 14595039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism.
    Chace DH; Kalas TA; Naylor EW
    Annu Rev Genomics Hum Genet; 2002; 3():17-45. PubMed ID: 12142359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutaric aciduria type 1 and neonatal screening: time to proceed--with caution.
    Superti-Furga A
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S17-20. PubMed ID: 14579152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCAD deficiency. Acylcarnitines (AC) by tandem mass spectrometry (MS-MS) are useful to monitor dietary treatment.
    Abdenur JE; Chamoles NA; Specola N; Schenone AB; Jorge L; Guinle A; Bernard CI; Levandowskiy V; Lavorgna S
    Adv Exp Med Biol; 1999; 466():353-63. PubMed ID: 10709663
    [No Abstract]   [Full Text] [Related]  

  • 15. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.
    Schulze A; Lindner M; Kohlmüller D; Olgemöller K; Mayatepek E; Hoffmann GF
    Pediatrics; 2003 Jun; 111(6 Pt 1):1399-406. PubMed ID: 12777559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for medium chain acyl-CoA dehydrogenase deficiency is being evaluated.
    Grosse S
    BMJ; 2001 Apr; 322(7293):1062. PubMed ID: 11349662
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal screening for inborn errors of metabolism.
    Morris AA
    Indian Pediatr; 2000 Dec; 37(12):1303-6. PubMed ID: 11119331
    [No Abstract]   [Full Text] [Related]  

  • 18. Technical aspects of neonatal screening using tandem mass spectrometry. Report from the 4th meeting of the International Society for Neonatal Screening.
    Simonsen H; Jensen UG
    Acta Paediatr Suppl; 1999 Dec; 88(432):52-4. PubMed ID: 10626579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency.
    Spiekerkoetter U; Sun B; Zytkovicz T; Wanders R; Strauss AW; Wendel U
    J Pediatr; 2003 Sep; 143(3):335-42. PubMed ID: 14517516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mass spectrometry and neonatal screening].
    Garnotel R
    Ann Biol Clin (Paris); 2015; 73(1):107-11. PubMed ID: 25582727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.